Maria Ali, George Clinical CMO, will be leading a panel discussion at this year’s CKD Summit. Maria will be joined by two of our scientific leaders, Jonathan Barratt andRoberto Pecoits-Filho.
The panel discussion, Enhancing Global Inclusion of Underserved Communities in CKD Trials for Greater Representation in Clinical Samples, will be held on Thursday, March 21, 9:00 AM.
Please reach out to Dan Gallagher to coordinate a meeting with the team and learn more about how our scientific expertise and services can benefit your CKD clinical trial project.
See you there!
Maria serves as the Chief Medical Officer for George Clinical, responsible for continuing to build the organization’s enviable network of investigators and scientific leaders. Previously, she led the medical and safety services group at George Clinical who provide safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. Maria has worked closely with the scientific leads at the George Institute to develop and implement scientific leadership models for George Clinical studies, as well as to develop new ideas for clinical research, and processes to improve clinical trial design and efficiencies. Maria has several years’ experience in both public health and clinical research as well as research management across a range of settings including hospitals, academic and clinical research organizations.
Professor Barratt focuses on glomerular disease, multi-system renal disease and complications of CKD, in particular renal associated anemia. He is The Mayer Professor of Renal Medicine & Honorary Consultant Nephrologist and leads the Renal Research Group within the College of Life Sciences University of Leicester, UK. He is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and a member of the steering committee for the International IgA Nephropathy Network.
Dr. Pecoits-Filho is a practicing Nephrologist and clinical investigator focused on evolving the way CKD patients are treated in day-to-day clinical practice by integrating observational research with clinical trials. He is the Scientific Director of the DOPPS program at Arbor Research Collaborative for Health, Michigan, and a professor of Medicine at the Pontifical Catholic University of Paraná, Brazil.
Boston, Massachusetts
Meet with George Clinical! Contact us to schedule a time now.